USPTO serial 79275407
RENALYSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- MAJCHER HARTNETT, MEGAN K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RENALYSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. Costanza
Kevin S. Costanza Seed IP Law Group LLP701 5th Avenue, Suite 5400Seattle, WA 98104UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded computer software for managing data and computer files and databases; downloadable software for remote monitoring and analysis of medical equipment to analyze, treat, develop, transfer, communicate and show medical data and recommendations to users; downloadable or recorded application software programs for medical equipment to analyze, treat, develop, transfer, communicate and show medical data and recommendations to users; data processors; apparatus for data processing in real time; downloadable or recorded computer programs relating to the medical field for the analysis, treatment, development, transfer, communication and follow-up of the medical data; downloadable or recorded software for remote diagnostics of the kidney, cardiac disease and personalized treatment; interactive downloadable databases in the field of health and well-being; recorded or downloadable software platforms for medical equipment for data transfer and managing communication channels between physician's or medical staff and other medical staff and patients; scientific instruments for measuring, detecting and monitoring, indicators and controllers, namely, electrochemical analyzer devices to measure, detect and monitor biologic biomarkers in nephrology and cardiology; apparatus for transmitting data, namely, transmitter of electronic signals for medical equipment, specifically for electrochemical devices; downloadable or recorded computer programs relating to the medical field for the analysis, treatment, development, transfer, communication and follow-up of the medical data; instruments for diagnosis, namely, electrochemical devices in the nature of colorimeters, Potentiometric and amperometric electrochemical devices, namely, devices that measure the potential between two electrodes under an open circuit potential for potentiometry and that measure the current when applying a constant polarization voltage for amperometry for scientific use; measuring apparatus, namely, electrochemical devices in the nature of electronic analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target biomolecules, chemicals, and biologics; sensors and detectors, namely, potentiometric colorimeters and amperometric paper and plastic-based sensors and detectors, namely, potentiometric electronic boards; detection apparatus, namely, electrochemical devices in the nature of electronic analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target biomolecules, chemicals, and biologics; remote control apparatus, namely, point of care devices, in particular, electronic devices for assisting care giving for seniors and people needing assistance, comprised of sensors for determining status of person and apparatus for sending electronic alerts to care givers; downloadable or recorded artificial intelligence software for health care for managing, monitoring and facilitating specific treatment of patients and recommendations; digital sensory devices, namely, electrochemical and colorimetric, potentiometric, amperometric, and colorimetric transducers; downloadable or recorded interactive software for managing, monitoring and facilitating specific treatment of patients and recommendations; instruments for diagnosis, namely, electrochemical devices in the nature of colorimeters, Potentiometric and amperometric electrochemical devices, namely, devices that measure the potential between two electrodes under an open circuit potential for potentiometry and that measure the current when applying a constant polarization voltage for amperometry for scientific use; apparatus for scientific and laboratory research, namely, electrochemical and colorimetric electric, flow pH, potentiometric, and amperometric meters; educational apparatus and simulators, namely, electrochemical and colorimetric electric, flow pH, potentiometric, amperometric meters | ACTIVE | — |
| 010 | Measuring sensors for measuring nephrological and cardiological biomarkers, for medical use; medical diagnostic instruments for monitoring patients suffering any degree of kidney and/or cardiac disease and for specifying personalized treatments and recommendations; tools for veterinary diagnosis for monitoring the pet with kidney and/or cardiac disease and specifying treatment and recommendations; apparatus for diagnostic testing for medical purposes for a follow-up of patients suffering any degree of kidney and/or cardiac disease, and specifying personalized treatments and recommendations; electronic monitoring apparatus for medical use, namely, point of care devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use; medical and veterinary apparatus and instruments, namely, point of care electrochemical devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use; detection apparatus for medical use, namely, point of care devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CreatSens Health, S.L.
- Other trademarks owned by CreatSens Health, S.L.
- Other trademarks owned by CreatSens Health, S.L.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named RENALYSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 22, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 19, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 20, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 2, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 2, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 2, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 30, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 10, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 22, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 22, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 22, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 7, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |